I'm sure you don't want them to stop producing product for the other distribution deals they recently announced. I don't recall them saying anything about those deals being structured the same as the CBD Life deal.

Many never fully grasped just how good a deal the CBD Life deal is, and not all distributors are going to agree to such terms. That means that the company must pay up front to produce the large quantities of product to be distributed. If sales are strong, they can reduce dilution with some of that revenue by buying back some or all convertible notes before they are converted.

They have 6 months from the time each tranche is accessed. That's the way it goes until the revenues come in, and that's why I've been saying for a long time now over and over again that you had best not count on news alone to push the pps to not just higher levels, but sustainable higher levels. That requires proof of success in the form of revenue growth.

We should see that happen this year, but I've also said for a very long time that my plan is all about what happens within 2 to 3 years of re-launch, and as I see it, the 4th quarter of 2019 was the re-launch, as defined by the start of large scale distribution. It's not going to happen overnight, but it's going to happen.